 |
|
Cholera Vaccination in Refugee Settings
Ronald J. Waldman, MD, MPH
JAMA. 1998;279:552-553.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
The sight of thousands of bodies piled 3 and 4 high along the roadsides that led from the city of Goma, Zaire, to Rwandan refugee camps in July 1994 was shocking even to the most seasoned relief workers. The Centers for Disease Control and Prevention (CDC) estimates that more than 45000 people died of Vibrio cholerae O1 and that more than 600000 were infected over the course of 3 weeks.1 Many kinds of assistance were offered, including a large quantity of cholera vaccine procured by the US Army from a Swedish manufacturer. The offer of free vaccine, and expressions of incredulity that accompanied its rejection by the United Nations High Commissioner for Refugees and the World Health Organization (WHO), were well documented on a television news program.2
Cholera has frequently been an important public health problem among refugees. The field effectiveness of oral rehydration therapy, . . . [Full Text of this Article]
From Basic Support for Institutionalizing Child Survival (BASICS), Arlington, Va (Dr Waldman).
RELATED ARTICLE
Treatment and Vaccination Strategies to Control Cholera in Sub-Saharan Refugee Settings: A Cost-effectiveness Analysis
Abdollah Naficy, Malla R. Rao, Christophe Paquet, Denise Antona, Alan Sorkin, and John D. Clemens
JAMA. 1998;279(7):521-525.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Cholera Vaccine in Refugee Settings
Sack et al.
JAMA 1998;280:600-602.
FULL TEXT
|
